Effects of a Pulmonary and Cardiovascular Rehabilitation Program

Launched by UNIVERSITY OF CAMPINAS, BRAZIL · Jan 11, 2025

Keywords

ClinConnect Summary

This clinical trial is looking at how a special rehabilitation program can help people with breathing and heart problems. The program aims to improve patients' ability to exercise, their quality of life, and their breathing after three months of participation. It is designed for people who have chronic lung diseases like COPD, asthma, or pulmonary fibrosis, as well as those with heart conditions such as heart attacks or chronic heart failure. To join the program, participants need a referral from their doctor and must meet certain health criteria to ensure they can safely participate.

If eligible, participants can expect to engage in a mix of exercises, including aerobic activities like walking on a treadmill or riding a stationary bike, as well as strength training for their arms and legs. They will also do special exercises to help improve their breathing. Throughout the program, health professionals will monitor their progress by checking their physical abilities and overall health. This study is important because it could help improve the lives of many people struggling with chronic respiratory and heart conditions.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Candidates for the pulmonary rehabilitation program: users diagnosed with chronic obstructive pulmonary disease (COPD), pulmonary emphysema, pulmonary fibrosis, asthma or other lung disease.
• • Candidates for the cardiovascular rehabilitation program: users diagnosed with acute myocardial infarction, myocardial revascularization surgery, coronary angioplasty, stable angina, valve replacement, chronic heart failure and who meet the criteria for phase III of cardiovascular rehabilitation.
• • Referral with medical clearance for rehabilitation
• Exclusion Criteria:
• • Patients with any contraindication to aerobic or muscle-strengthening physical exercise, such as significant arrhythmias, untreated heart disease, myocarditis, recent or untreated pulmonary embolism, and uncontrolled systemic arterial hypertension, among other conditions.